Sanobiotec is a cannabinoid science company committed to identification, development and formulation of innovative active compounds via extraction, synthesis and biosynthesis. Headquartered in Vilnius, Lithuania, the company operates a state-of-the-art laboratory and develops proprietary technological solutions designed for production of natural and custom compounds. Sanobiotec is also engaged in scientific projects investigating the potential of cannabinoid-based medications used for treatment of specific diseases and holder of licence to work with Schedule 1 substances for R&D purposes.